As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...